TY - JOUR
T1 - ADMINISTRATION OF LIVE VARICELLA VACCINE TO CHILDREN WITH LEUKAEMIA
AU - Brunell, Philip A.
AU - Geiser, Clementina
AU - Shehab, Ziad
AU - Waugh, Jane E.
N1 - Funding Information:
was supported by grant AICA 15492 from the Public Health Service National Institute of Allergy and Infectious Diseases.
PY - 1982/11/13
Y1 - 1982/11/13
N2 - Live varicella vaccine was given to twenty-three children with lymphoreticular malignancies, twelve whose chemotherapy was complete and eleven who were still receiving therapy. Seroconversion was observed in all twenty-three children, only one of whom lost his vaccine-induced antibody. Eight of the children experienced thirteen exposures to varicella, including four continuing exposures in their households. Varicella, manifested by the appearance of seven vesicular lesions, developed in only one. In all but two of the children an in-vitro blastogenic response to varicella/zoster-virus (VZV) antigen developed; both children had a biphasic rash after immunisation. A sibling of one of these children seroconverted without clinical evidence of varicella, presumably because of infection with vaccine virus. None of the other household contacts had significant rises in VZV antibody. VZV was not isolated from the blood, throat, or urine samples of the twenty-three vaccinees tested.
AB - Live varicella vaccine was given to twenty-three children with lymphoreticular malignancies, twelve whose chemotherapy was complete and eleven who were still receiving therapy. Seroconversion was observed in all twenty-three children, only one of whom lost his vaccine-induced antibody. Eight of the children experienced thirteen exposures to varicella, including four continuing exposures in their households. Varicella, manifested by the appearance of seven vesicular lesions, developed in only one. In all but two of the children an in-vitro blastogenic response to varicella/zoster-virus (VZV) antigen developed; both children had a biphasic rash after immunisation. A sibling of one of these children seroconverted without clinical evidence of varicella, presumably because of infection with vaccine virus. None of the other household contacts had significant rises in VZV antibody. VZV was not isolated from the blood, throat, or urine samples of the twenty-three vaccinees tested.
UR - http://www.scopus.com/inward/record.url?scp=0019904286&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0019904286&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(82)90006-X
DO - 10.1016/S0140-6736(82)90006-X
M3 - Article
C2 - 6127546
AN - SCOPUS:0019904286
SN - 0140-6736
VL - 320
SP - 1069
EP - 1073
JO - The Lancet
JF - The Lancet
IS - 8307
ER -